Manufacturer
NOVARTIS PHARMA STEIN AG
Contents
Synthetic oxytocin
Indication
Postpartum haemorrhage, Adjunct in abortion, Labour induction, Oxytocin challenge test for evaluating of fetal distress.
Instruction
Administer via IV infusion.
Drug interaction
Possible severe hypertension if given within 3-4 hr of vasoconstrictor in association with a caudal block anaesthesia. Cyclopropane anaesthesia may increase risk of hypotension and maternal sinus bradycardia with abnormal AV rhythms. Dinoprostone and misoprostol may increase uterotonic effect of oxytocin, thus oxytocin should not be used within 6 hr after admin of vaginal prostaglandins. Concurrent use may increase the vasopressor effect of sympathomimetics. Potentially Fatal: Concomitant use with prostaglandins increases risk of uterine rupture and cervical lacerations.
Malaysia
